Lv11
18 积分 2024-04-15 加入
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
1小时前
已完结
Glycyrrhizic acid promote remyelination after peripheral nerve injury by reducing NF-κB activation
1个月前
已完结
皖公网安备34019202002308
